Similar articles for PMID: 16000339

Year	Number of Results
1999	2
2001	2
2002	13
2003	6
2004	7
2005	11
2006	9
2007	5
2008	6
2009	10
2010	14
2011	8
2012	9
2013	11
2014	12
2015	2
2017	1
2024	0

1

Cisplatin and gemcitabine in malignant mesothelioma.

Nowak AK, Byrne MJ. Nowak AK, et al. Ann Oncol. 2005 Oct;16(10):1711. doi: 10.1093/annonc/mdi303. Epub 2005 Jul 6. Ann Oncol. 2005. PMID: 16000339 Free article. No abstract available.

2

Novel combinations using pemetrexed in malignant mesothelioma.

Gadgeel SM, Pass HI. Gadgeel SM, et al. Clin Lung Cancer. 2004 Apr;5 Suppl 2:S61-6. doi: 10.3816/clc.2004.s.005. Clin Lung Cancer. 2004. PMID: 15117427 Review.

3

Comparison of cisplatin plus pemetrexed and cisplatin plus gemcitabine for the treatment of malignant pleural mesothelioma in Japanese patients.

Shukuya T, Takahashi T, Imai H, Tokito T, Ono A, Akamatsu H, Taira T, Kenmotsu H, Naito T, Murakami H, Endo M, Yamamoto N. Shukuya T, et al. Respir Investig. 2014 Mar;52(2):101-6. doi: 10.1016/j.resinv.2013.07.002. Epub 2013 Sep 13. Respir Investig. 2014. PMID: 24636265

4

Chemotherapy management of malignant pleural mesothelioma: a phase II study comparing two popular chemotherapy regimens.

Habib EE, Fahmy ES. Habib EE, et al. Clin Transl Oncol. 2013 Nov;15(11):965-8. doi: 10.1007/s12094-013-1015-3. Epub 2013 Feb 14. Clin Transl Oncol. 2013. PMID: 23408040 Clinical Trial.

5

Gemcitabine, pemetrexed, and novel agents in the treatment of thoracic cancer. Selected presentations from the 10th World Congress on Lung Cancer. Vancouver, Canada.

[No authors listed] [No authors listed] Oncology (Williston Park). 2004 Jul;18(8 Suppl 5):5-71. Oncology (Williston Park). 2004. PMID: 15675032 No abstract available.

6

Systemic chemotherapy in the management of malignant peritoneal mesothelioma.

Garcia-Carbonero R, Paz-Ares L. Garcia-Carbonero R, et al. Eur J Surg Oncol. 2006 Aug;32(6):676-81. doi: 10.1016/j.ejso.2006.03.009. Epub 2006 Apr 17. Eur J Surg Oncol. 2006. PMID: 16616827 Review.

7

Chemotherapy options and new advances in malignant pleural mesothelioma.

Steele JP, Klabatsa A. Steele JP, et al. Ann Oncol. 2005 Mar;16(3):345-51. doi: 10.1093/annonc/mdi094. Epub 2005 Jan 27. Ann Oncol. 2005. PMID: 15677623 Free article. Review.

8

Gemcitabine and vinorelbine as second-line or beyond treatment in patients with malignant pleural mesothelioma pretreated with platinum plus pemetrexed chemotherapy.

Toyokawa G, Takenoyama M, Hirai F, Toyozawa R, Inamasu E, Kojo M, Morodomi Y, Shiraishi Y, Takenaka T, Yamaguchi M, Shimokawa M, Seto T, Ichinose Y. Toyokawa G, et al. Int J Clin Oncol. 2014 Aug;19(4):601-6. doi: 10.1007/s10147-013-0619-5. Epub 2013 Oct 26. Int J Clin Oncol. 2014. PMID: 24158772

9

Gemcitabine and vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma.

Zucali PA, Ceresoli GL, Garassino I, De Vincenzo F, Cavina R, Campagnoli E, Cappuzzo F, Salamina S, Soto Parra HJ, Santoro A. Zucali PA, et al. Cancer. 2008 Apr 1;112(7):1555-61. doi: 10.1002/cncr.23337. Cancer. 2008. PMID: 18286536 Free article. Clinical Trial.

10

[Malignant pleural mesothelioma].

Nishiwaki Y. Nishiwaki Y. Gan To Kagaku Ryoho. 2003 May;30(5):589-94. Gan To Kagaku Ryoho. 2003. PMID: 12795087 Review. Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

116 results

Results by year